Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
AMPH
$25.30
-0.28%
AMPH
· Amphastar Pharmaceuticals, Inc.
$25.30
-0.07 (-0.28%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$1.17B
Shares
42.54M
Volume · Oct 5
454.52K
Avg daily vol (3M)
464.78K
All webcasts
Earnings call · FY2024 Q2
Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$182.39M
+25.2% YoY
Diluted EPS
$0.73
+49% YoY
Gross margin
52.2%
+2.3 pp YoY
Net income
$37.95M
+45.3% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 7, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 9, 2024 · complete as-filed document